Opendata, web and dolomites


NORATEST: An e-Health solution for a better Alzheimer's diagnosis and management

Total Cost €


EC-Contrib. €






 NORATEST project word cloud

Explore the words cloud of the NORATEST project. It provides you a very rough idea of what is the project "NORATEST" about.

lack    pay    diagnosis    healthy    company    ddiagnosis    detectable    projected    12    computer    gt    anticipating    first       ones    revenue    improvements    algorithm    innovative    motivated    coupled    2016       accumulate    speed    5m    cagr    2026    market    direct    accounting    sales    people    alzheimer    total    fast    medical    2024    adaptable    diseases    usa    diagnoses    prototype    producing    biomarkers    blood    detecting    platform    signatures    dementia    alzohis    disease    health    efficiency    detect    countries    earn    360k    neurodegenerative    tests    smart    privacy    noratest    solution    competitive    roi    accurate    business    discriminate    80m    2030    annual    diagnostic    scalable    advantages    stages    markets    hire    suffering    efficient    worth    detection    ad    profit    care    charging    shows    combination    analytics    2050    molecular    17    worldwide    duplicating    combined    leaders    employees    model    almost    affordable    32m    global    trl6    issue    online    invasive    data    reference    54m    patients   

Project "NORATEST" data sheet

The following table provides information about the project.


Organization address
city: PARIS
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALZOHIS FR (PARIS) coordinator 50˙000.00


 Project objective

Alzheimer's disease (AD) is a major medical problem and is currently an issue of global general interest as the total number of people with dementia is projected to reach ~80M in 2030 and almost duplicating this number by 2050. The lack of an efficient and affordable solution in the AD's health care sector has motivated our company Alzohis to develop NORATEST, a very unique and innovative e-Health platform producing significant improvements, in terms of speed efficiency, in the detection of neurodegenerative diseases. By means of a novel combination of biomarkers “signatures” detectable in the blood with a state-of-the-art computer algorithm NORATEST can discriminate patients suffering AD from those healthy ones, as well as detecting other neurodegenerative diseases. Our prototype, currently at TRL6, is the first reliable non-invasive molecular diagnostic method able to detect the disease in the very early stages, offering several competitive and innovative advantages such as: Cost-effective novel technology, fast, accurate, early ddiagnosis, data privacy coupled to smart analytics, user-friendly and highly scalable and adaptable platform. Our business model is a pay-per-use combined model of charging per analysis and direct online sales. The global AD market shows great opportunities for us since it was worth €2.5 B in 2016 and is set to reach €12.6 B by 2026 (CAGR of 17.5%). Worldwide we expect a market growth in both established and in developing countries, anticipating >5M annual AD's diagnoses in the two main markets leaders based in Europe (2.5-3.5M diagnoses/year) and USA (1.5-2.5M diagnoses/year) by 2024. Our company goal is to become the reference for AD's diagnosis in Europe. We estimated that in 5 years (end of Phase 2 project), we will accumulate 360K diagnosis tests sales (revenue €54M) accounting for ~2% of the EU and USA market. We expect to hire 40 new technical and sales employees and earn ~€32M profit, with a ROI of 6.5.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NORATEST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NORATEST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Presque (2019)

Smart Nursing Bra

Read More  

HUD (2018)


Read More